Skip to main content
. 2019 Jan 19;6(2):222–232. doi: 10.1002/acn3.674

Table 1.

Baseline demographics and clinical characteristics

RRMS SPMS PPMS P‐value
Number of patients (%) 151 (87.8) 14 (8.1) 7 (4.1) <0.0001
Age at first OCT; mean, years (SD) 39.4 (9.9) 51.7 (5.8) 49.9 (8.3) <0.0001 a
Females; n (%) 120 (79.5) 10 (71.4) 4 (57.1) 0.22b
Race; n (%)
Caucasian 122 (80.8) 14 (100.0) 6 (85.7) 0.74b
African American 21 (13.9) 0 (0.0) 1 (14.3)
Hispanic 3 (2.0) 0 (0.0) 0 (0.0)
Asian‐Pacific Islander 1 (0.7) 0 (0.0) 0 (0.0)
Other 4 (2.7) 0 (0.0) 0 (0.0)
Disease Duration; mean, years (SD) 15.9 (6.7) 30.4 (9.0) 16.1 (3.9) <0.0001 a
Optic neuritis history; n (%) 70 (46.4) 6 (42.9) 0 (0.0) 0.11b
Follow‐up duration; mean, years (SD) 9.4 (0.7) 9.5 (0.7) 9.5 (0.5) 0.90a
Baseline EDSS; mean (SD) 2.0 (1.4) 5.5 (1.9) 4.8 (1.5) <0.0001 b

RRMS, relapsing remitting multiple sclerosis; SPMS, secondary progressive multiple sclerosis; PPMS, primary progressive multiple sclerosis; OCT, Optical coherence tomography; EDSS, Expanded Disability Status Scale.

a

Determined by Kruskal–wallis equality‐of‐population rank test.

b

Determined by Fisher'sexact test.